M
37
12
SYK
64
-4
AAP
24
6
HCP
66
8
INTU
56
-4
WFC
79
4
BK
74
2
CL
58
2
JWN
48
6
PAYX
53
2
AA
48
-12
TGT
22
2
PFG
45
3
DG
6
2
DVN
21
3
KEY
46
3
NWL
53
3
MSFT
50
3
RIG
60
2
AN
58
4
M
37
12
SYK
64
-4
AAP
24
6
HCP
66
8
INTU
56
-4
WFC
79
4
BK
74
2
CL
58
2
JWN
48
6
PAYX
53
2
AA
48
-12
TGT
22
2
PFG
45
3
DG
6
2
DVN
21
3
KEY
46
3
NWL
53
3
MSFT
50
3
RIG
60
2
AN
58
4
Financhill
Back

Takeda Pharmaceutical Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

TAK
Takeda Pharmaceutical

Last Price:
13.37
Seasonality Move:
5.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Takeda Pharmaceutical Price Quote

$13.37
-0.01 (0.3%)
(Updated: November 23, 2024 at 5:56 AM ET)

Takeda Pharmaceutical Key Stats

Sell
20
Takeda Pharmaceutical (TAK) is a Sell
Day range:
$13.30 - $13.42
52-week range:
$12.58 - $15.08
Dividend yield:
4.57%
P/E ratio:
42.36
P/S ratio:
1.41
P/B ratio:
0.88%
Volume:
1.6M
Avg. volume:
1.7M
1-year change:
-4.43%
Market cap:
$42.4B
Revenue:
$29.5B
EPS:
$0.6

How Much Does Takeda Pharmaceutical Make?

Is Takeda Pharmaceutical Growing As A Company?

  • What Is Takeda Pharmaceutical's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.1%
  • What Is Takeda Pharmaceutical's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Takeda Pharmaceutical Stock Price Performance

What Is Takeda Pharmaceutical 52-Week High & Low?

Takeda Pharmaceutical Price To Free Cash Flow

Is It Risky To Buy Takeda Pharmaceutical?

Is Takeda Pharmaceutical Cash Flow Positive?

  • What Is TAK Cash Flow From Operations?
    Cash flow from operations (TTM) is $6B
  • What Is Takeda Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $306.8M
  • What Is Takeda Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.5B

Takeda Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    TAK return on invested capital is 2.37%
  • What Is Takeda Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is 1.91%
  • What Is TAK Return On Equity?
    ROE is a measure of profitability and is 4.01%

Takeda Pharmaceutical Earnings Date & Stock Price

Takeda Pharmaceutical Competitors

Takeda Pharmaceutical Dividend Yield

Takeda Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 9.64% 6.41%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 16.04
Upside from Last Price: 19.88%

Major Shareholders

  • How many TAK shares are owned by institutional investors?
    197.3M TAK shares are owned by institutional investors
  • How many TAK shares are owned by insiders?
    0 TAK shares are owned by insiders